Rhythm Pharmaceuticals (RYTM) Work In Process (2023 - 2025)
Historic Work In Process for Rhythm Pharmaceuticals (RYTM) over the last 3 years, with Q3 2025 value amounting to $387000.0.
- Rhythm Pharmaceuticals' Work In Process fell 5392.86% to $387000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $387000.0, marking a year-over-year decrease of 5392.86%. This contributed to the annual value of $1.2 million for FY2024, which is 1322.46% up from last year.
- Per Rhythm Pharmaceuticals' latest filing, its Work In Process stood at $387000.0 for Q3 2025, which was down 5392.86% from $767000.0 recorded in Q2 2025.
- Rhythm Pharmaceuticals' Work In Process' 5-year high stood at $3.5 million during Q3 2023, with a 5-year trough of $387000.0 in Q3 2025.
- In the last 3 years, Rhythm Pharmaceuticals' Work In Process had a median value of $1.5 million in 2024 and averaged $1.7 million.
- Examining YoY changes over the last 5 years, Rhythm Pharmaceuticals' Work In Process showed a top increase of 1322.46% in 2024 and a maximum decrease of 7598.63% in 2024.
- Over the past 3 years, Rhythm Pharmaceuticals' Work In Process (Quarter) stood at $1.1 million in 2023, then grew by 13.22% to $1.2 million in 2024, then plummeted by 69.04% to $387000.0 in 2025.
- Its Work In Process was $387000.0 in Q3 2025, compared to $767000.0 in Q2 2025 and $1.7 million in Q1 2025.